Long Term Effect of AIT in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4-18
SponsorOdense University Hospital

About this trial

The present study will investigate the long term effect of allergen immunotherapy in a real-life study in children with allergy undergoing subcutaneous or sublingual immunotherapy with grass pollen, birch, house dust mites or venom.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Children with moderate to severe allergy to grass pollen, birch, house dust mites or venom who are prescribed allergen immunotherapy

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Allergen Immunotherapy Extract

    Drug

    Patients will be treated as usual. The study is an observation of the long term effect of the treatment

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Effect of immunotherapy 5 years after end of treatment

Medication use for allergy and asthma and the patient's experience of effect of the AIT on a scale from 0-4 (0= no effect, 1= modest effect, 2= some effect, 3= good effect, 4= very good effect)

Time frame
5 years

Secondary outcomes

1

Effect of immunotherapy 10 years after end of treatment

Medication use for allergy and asthma and the patient's experience of effect of the AIT on a scale from 0-4 (0= no effect, 1= modest effect, 2= some effect, 3= good effect, 4= very good effect)

Time frame
10 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.